Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The trial is being conducted to establish the bioequivalence of emp/met (12.5mg/500mg) fixed
dose combination tablets compared to tablets administered together in healthy male and female
volunteers under fed conditions.